Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Hereditary Cancer Testing Market Growth Evolved From 2024 To 2025, And What’s Ahead?
The size of the hereditary cancer testing market has seen robust growth in the past few years. From reaching $4.32 billion in 2024, it is projected to increase to $4.75 billion in 2025, with a compound annual growth rate (CAGR) of 10.0%. The surge in growth observed in the historical era could be a result of a higher prevalence of hereditary cancers, launch of genetic counseling programs, government-led cancer prevention strategies, better insurance protection, increased awareness about gene-environment interplay, and the rise of patient advocacy and support groups.
The market size for hereditary cancer testing is predicted to witness a swift expansion in the coming years. The market is estimated to surge to $7.27 billion in 2029 with a compound annual growth rate (CAGR) of 11.3%. The projected growth during this period can be linked to the broadening of targeted therapies, progression in precision medicine, an increase in direct-to-consumer testing, worldwide health campaigns, and advancements in bioinformatics. Key trends anticipated during the forecast period encompass advancements in genetic sequencing technologies, telemedicine and remote genetic counselling, precision medicine and personalised treatment, cancer risk assessment models, along with ethical and legal aspects.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8121&type=smp
What are the Fundamental Drivers and Innovations Shaping the Hereditary Cancer Testing Market?
The hereditary cancer testing market expansion is anticipated due to the growing incidents of inherited cancer. These cancer syndromes are caused by certain genetic alterations that are transferred from parents to offspring. Testing for hereditary cancer can discover distinct inheritable gene alterations linked to the disease, enabling a thorough cancer risk evaluation for patients. For instance, a June 2022 article published on BioMed Central about hereditary cancer in clinical practice revealed that almost 10% of cases of pancreatic cancer are caused by genetics. As a result, the surge in hereditary cancer cases propels the advancement of the hereditary cancer testing market.
How Is the Hereditary Cancer Testing Market Segmented?
The hereditary cancer testingmarket covered in this report is segmented –
1) By Test Type: Multi Panel Test; Single-Site Genetic Test
2) By Indication: Breast Cancer; Ovarian Cancer; Colorectal Cancer; Other Indications
3) By End user: Hospital; Clinics; Diagnostic Centers
Subsegments:
1) By Multi Panel Test: Comprehensive Genetic Panels; Targeted Gene Panels
2) By Single-Site Genetic Test: Specific Gene Testing; Familial Mutation Testing
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8121&type=smp
Which Regions Are Driving the Next Phase of the Hereditary Cancer Testing Market Growth?
North America was the largest region in the hereditary cancer testing market in 2024. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Hereditary Cancer Testing Market?
The hereditary cancer testing market is increasingly being driven by technological innovation. To maintain their dominance in the market, key players are emphasizing on technological advancements. An example of this trend can be seen in March 2022, when Myriad Genetics, an American company specializing in genetic testing and precision medicine, unveiled a new genetic test that includes a Polygenic Breast Cancer Risk Assessment Score suitable for all ancestral backgrounds. Their MyRisk Hereditary Cancer test with RiskScore provides a tailored breast cancer risk evaluation for all women who have not been previously diagnosed with breast cancer, irrespective of their ancestry.
View the full report here:
https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report
How Is the Hereditary Cancer Testing Market Defined and What Are Its Core Parameters?
The hereditary cancer testing refers to testing methods for hereditary cancers that can identify specific hereditary cancer diseases and disease-related gene mutations. This testing may decrease the risk of developing particular cancer mutants, allowing for a more comprehensive cancer risk for patients. The primary purpose of this cancer testing is to detect hereditary cancer early and maximize patient health outcomes. This testing procedure assists in identifying cancers for which one has a genetic risk and allows them to receive preventive treatment.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8121
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model